Author

Paolo Ingallinella

Observed names: Ingallinella, P., Ingallinella, Paolo, P. Ingallinella, Paolo Ingalinella

Observed institutions: Merck & Co., Inc., Rahway, NJ, USA (United States), Institute of Molecular Biology and Pathology, IRBM, National Research Council, Indian Institute of Science Bangalore, University of Naples Federico II

OpenAlex ID: A5014423238

Addition of a cholesterol group to an HIV-1 peptide fusion inhibitor dramatically increases its antiviral potency

2009 · Paolo Ingallinella, Elisabetta Bianchi, et al. · Proceedings of the National Academy of Sciences · 220

Potent Peptide Inhibitors of Human Hepatitis C Virus NS3 Protease Are Obtained by Optimizing the Cleavage Products

1998 · Paolo Ingallinella, Sergio Altamura, et al. · Biochemistry · 171

A human monoclonal antibody neutralizes diverse HIV-1 isolates by binding a critical gp41 epitope

2005 · Michael D. Miller, Romas Geleziunas, et al. · Proceedings of the National Academy of Sciences · 158

Structural Analysis of the Epitope of the Anti-HIV Antibody 2F5 Sheds Light into Its Mechanism of Neutralization and HIV Fusion

2003 · Gaetano Barbato, Elisabetta Bianchi, et al. · Journal of Molecular Biology · 136

Structure of a proteolytically resistant core from the severe acute respiratory syndrome coronavirus S2 fusion protein

2004 · Vinit M. Supekar, Chiara Bruckmann, et al. · Proceedings of the National Academy of Sciences · 120

PDF

Covalent stabilization of coiled coils of the HIV gp41 N region yields extremely potent and broad inhibitors of viral infection

2005 · Elisabetta Bianchi, Marco Finotto, et al. · Proceedings of the National Academy of Sciences · 101

Ligands for κ-Opioid and ORL1 Receptors Identified from a Conformationally Constrained Peptide Combinatorial Library

1999 · Jérôme A.J. Becker, Andrew Wallace, et al. · Journal of Biological Chemistry · 101

PDF

Structural characterization of the fusion-active complex of severe acute respiratory syndrome (SARS) coronavirus

2004 · Paolo Ingallinella, Elisabetta Bianchi, et al. · Proceedings of the National Academy of Sciences · 84

PDF

Universal Influenza B Vaccine Based on the Maturational Cleavage Site of the Hemagglutinin Precursor

2005 · Elisabetta Bianchi, Xiaoping Liang, et al. · Journal of Virology · 77

DPP‐IV‐resistant, long‐acting oxyntomodulin derivatives

2011 · Alessia Santoprete, Elena Capitò, et al. · Journal of Peptide Science · 64

Structural characterization of the interactions of optimized product inhibitors with the N-terminal proteinase domain of the hepatitis C virus (HCV) NS3 protein by NMR and modelling studies

1999 · Daniel O Cicero, Gaetano Barbato, et al. · Journal of Molecular Biology · 60

PDF

Vaccination with peptide mimetics of the gp41 prehairpin fusion intermediate yields neutralizing antisera against HIV-1 isolates

2010 · Elisabetta Bianchi, Joseph G. Joyce, et al. · Proceedings of the National Academy of Sciences · 57

Prime Site Binding Inhibitors of a Serine Protease: NS3/4A of Hepatitis C Virus

2002 · Paolo Ingallinella, Daniela Fattori, et al. · Biochemistry · 56

PDF

Surface topology of Minibody by selective chemical modifications and mass spectrometry

1997 · Francesca Zappacosta, Paolo Ingallinella, et al. · Protein Science · 48

PEGylation of Neuromedin U yields a promising candidate for the treatment of obesity and diabetes

2012 · Paolo Ingallinella, Andrea M. Peier, et al. · Bioorganic & Medicinal Chemistry · 42

A PEGylated analog of the gut hormone oxyntomodulin with long-lasting antihyperglycemic, insulinotropic and anorexigenic activity

2013 · Elisabetta Bianchi, Paul E. Carrington, et al. · Bioorganic & Medicinal Chemistry · 41

Protein Minimization of the gp120 Binding Region of Human CD4

2005 · Deepak Sharma, M. M. Balamurali, et al. · Biochemistry · 39

Optimization of the P‘-Region of Peptide Inhibitors of Hepatitis C Virus NS3/4A Protease

2000 · Paolo Ingallinella, Elisabetta Bianchi, et al. · Biochemistry · 37

Development of a neuromedin U–human serum albumin conjugate as a long‐acting candidate for the treatment of obesity and diabetes. Comparison with the PEGylated peptide

2013 · Philippe Neuner, Andrea M. Peier, et al. · Journal of Peptide Science · 31

A New Method for Chemoselective Conjugation of Unprotected Peptides to Dauno- and Doxorubicin

2001 · Paolo Ingallinella, Annalise Di Marco, et al. · Bioorganic & Medicinal Chemistry Letters · 15

A practical approach to the synthesis of hairpin polyamide–peptide conjugates through the use of a safety-catch linker

2002 · Daniela Fattori, Olaf Kinzel, et al. · Bioorganic & Medicinal Chemistry Letters · 10

Structural Investigations on Human Erythrocyte Acylpeptide Hydrolase by Mass Spectrometric Procedures

1999 · Andrea Scaloni, Paolo Ingallinella, et al. · Journal of Protein Chemistry · 10

The effect of prime‐site occupancy on the hepatitis C virus NS3 protease structure

2002 · Annarita Casbarra, Fabrizio Dal Piaz, et al. · Protein Science · 8

PDF

A new isoluminol reagent for chemiluminescence labeling of proteins

2013 · Alessandro Palmioli, Marco Crisma, et al. · Tetrahedron Letters · 6

A machine learning model including pentraxin-3 as predictor of outcomes in community-acquired pneumonia

2025 · Antonio Voza, Stefano Aliberti, et al. · Journal of Translational Medicine · 5

PDF

Works count: 46

Citation count: 1,707

H-index: 19

I10-index: 22